List of Nektar (pulminary therapeutics business unit) patents

Patent 6901929 was granted and assigned to Nektar (pulminary therapeutics business unit) on June, 2005 by the United States Patent and Trademark Office.

Patent 7422013 was granted and assigned to Nektar (pulminary therapeutics business unit) on September, 2008 by the United States Patent and Trademark Office.

Patent 7964217 was granted and assigned to Nektar (pulminary therapeutics business unit) on June, 2011 by the United States Patent and Trademark Office.

Patent 6946117 was granted and assigned to Nektar (pulminary therapeutics business unit) on September, 2005 by the United States Patent and Trademark Office.

Patent 6941980 was granted and assigned to Nektar (pulminary therapeutics business unit) on September, 2005 by the United States Patent and Trademark Office.

Patent 9149588 was granted and assigned to Nektar (pulminary therapeutics business unit) on October, 2015 by the United States Patent and Trademark Office.

Patent 9084862 was granted and assigned to Nektar (pulminary therapeutics business unit) on July, 2015 by the United States Patent and Trademark Office.

Patent 7087197 was granted and assigned to Nektar (pulminary therapeutics business unit) on August, 2006 by the United States Patent and Trademark Office.

Patent 7744861 was granted and assigned to Nektar (pulminary therapeutics business unit) on June, 2010 by the United States Patent and Trademark Office.

Patent 7393544 was granted and assigned to Nektar (pulminary therapeutics business unit) on July, 2008 by the United States Patent and Trademark Office.

Patent 7834088 was granted and assigned to Nektar (pulminary therapeutics business unit) on November, 2010 by the United States Patent and Trademark Office.

Patent 7306787 was granted and assigned to Nektar (pulminary therapeutics business unit) on December, 2007 by the United States Patent and Trademark Office.

Patent 7300919 was granted and assigned to Nektar (pulminary therapeutics business unit) on November, 2007 by the United States Patent and Trademark Office.

Patent 7608663 was granted and assigned to Nektar (pulminary therapeutics business unit) on October, 2009 by the United States Patent and Trademark Office.

Patent 7482024 was granted and assigned to Nektar (pulminary therapeutics business unit) on January, 2009 by the United States Patent and Trademark Office.

Patent 7786133 was granted and assigned to Nektar (pulminary therapeutics business unit) on August, 2010 by the United States Patent and Trademark Office.

Patent 6890518 was granted and assigned to Nektar (pulminary therapeutics business unit) on May, 2005 by the United States Patent and Trademark Office.

Patent 7582284 was granted and assigned to Nektar (pulminary therapeutics business unit) on September, 2009 by the United States Patent and Trademark Office.

Patent 6899898 was granted and assigned to Nektar (pulminary therapeutics business unit) on May, 2005 by the United States Patent and Trademark Office.

Patent RE39497 was granted and assigned to Nektar (pulminary therapeutics business unit) on February, 2007 by the United States Patent and Trademark Office.

Patent 7473433 was granted and assigned to Nektar (pulminary therapeutics business unit) on January, 2009 by the United States Patent and Trademark Office.

Patent 7112341 was granted and assigned to Nektar (pulminary therapeutics business unit) on September, 2006 by the United States Patent and Trademark Office.

Patent 7368102 was granted and assigned to Nektar (pulminary therapeutics business unit) on May, 2008 by the United States Patent and Trademark Office.

Patent 7786221 was granted and assigned to Nektar (pulminary therapeutics business unit) on August, 2010 by the United States Patent and Trademark Office.

Patent 7872082 was granted and assigned to Nektar (pulminary therapeutics business unit) on January, 2011 by the United States Patent and Trademark Office.